varespladib has been researched along with Encephalopathy, Toxic in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
GutiƩrrez, JM; Lewin, MR; Lomonte, B; Williams, DJ | 1 |
Fontana Oliveira, IC; GutiƩrrez, JM; Lewin, MR; Oshima-Franco, Y | 1 |
2 other study(ies) available for varespladib and Encephalopathy, Toxic
Article | Year |
---|---|
Varespladib (LY315920) and Methyl Varespladib (LY333013) Abrogate or Delay Lethality Induced by Presynaptically Acting Neurotoxic Snake Venoms.
Topics: Acetates; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Indoles; Keto Acids; Lethal Dose 50; Mice; Neurotoxicity Syndromes; Phospholipase A2 Inhibitors; Phospholipases A2; Snake Bites; Snake Venoms; Survival Analysis; Time Factors | 2020 |
Varespladib (LY315920) inhibits neuromuscular blockade induced by Oxyuranus scutellatus venom in a nerve-muscle preparation.
Topics: Acetates; Antivenins; Elapid Venoms; Indoles; Keto Acids; Neuromuscular Blockade; Neuromuscular Diseases; Neuromuscular Junction; Neurotoxicity Syndromes; Neurotoxins; Snake Bites | 2020 |